Literature DB >> 3303427

Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

M M Clay, S W Clarke.   

Abstract

A radioaerosol technique has been used to investigate whether the size distribution of aerosols released from a jet nebuliser affects the amount of aerosol delivered to the lungs. Six subjects with mild asthma (FEV1 81% of predicted) were studied on three occasions. On each visit they received one of three aerosols tagged with technetium-99m in 0.9% saline. The aerosols were generated by either (A) a Turret nebuliser operated at 8 l min-1 (mass median diameter (MMD) 1.8 micron); (B) an Upmist nebuliser operated at 6 l min-1 (MMD 4.6 microns); or (C) an Inspiron Mini-neb operated at 4 l min-1 (MMD 10.3 microns). The aerosols were given in a randomised single blind manner and inhaled under identical conditions of inspiratory volume and frequency. The mean (SD) percentage of aerosols A, B, C released from the nebulisers during inhalation that was recovered in an expiratory filter was 23 (6), 25 (4), and 24 (4) respectively. Of the aerosols released from the nebuliser and deposited in the body, the percentage deposited in the lung was 79 (3) for aerosol A, 59 (4) for aerosol B, and 44 (5) for aerosol C. The remaining aerosol was deposited in the oropharynx and swallowed. It is concluded that small nebulised aerosols (MMD less than 2 microns) deliver a larger dose to the lungs and should be used to maximise lung deposition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3303427      PMCID: PMC460687          DOI: 10.1136/thx.42.3.190

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Efficiency of nebulizers for depositing saline in human lung.

Authors:  T Asmundsson; R F Johnson; K H Kilburn; J K Goodrich
Journal:  Am Rev Respir Dis       Date:  1973-09

2.  The importance of particle size in response to inhaled bronchodilators.

Authors:  P J Rees; T J Clark; F Morén
Journal:  Eur J Respir Dis Suppl       Date:  1982

3.  Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects.

Authors:  C M Salome; R E Schoeffel; A J Woolcock
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

4.  Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation.

Authors:  G Ryan; M B Dolovich; G Obminski; D W Cockcroft; E Juniper; F E Hargreave; M T Newhouse
Journal:  J Allergy Clin Immunol       Date:  1981-02       Impact factor: 10.793

5.  Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics.

Authors:  S Larsson; N Svedmyr
Journal:  Am Rev Respir Dis       Date:  1977-11

6.  Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.

Authors:  D Pavia; M L Thomson; S W Clarke; H S Shannon
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

7.  Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose.

Authors:  R E Ruffin; M C Kenworthy; M T Newhouse
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

8.  Lung clearance of soluble radioaerosols of different molecular weights in systemic sclerosis.

Authors:  S K Chopra; G V Taplin; D P Tashkin; D Elam
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

9.  Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation.

Authors:  S A Gomm; N P Keaney; L P Hunt; S C Allen; T B Stretton
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

10.  Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.

Authors:  M M Clay; D Pavia; S W Clarke
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

View more
  10 in total

Review 1.  The science of nebulised drug delivery.

Authors:  C O'Callaghan; P W Barry
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 2.  Aerosols for therapy and diagnosis.

Authors:  M J O'Doherty; R F Miller
Journal:  Eur J Nucl Med       Date:  1993-12

Review 3.  Inhaled beta-2 agonists and steroids. Present state and future perspectives.

Authors:  A M Clauzel
Journal:  Clin Rev Allergy       Date:  1994

Review 4.  Studies using radiolabelled aerosols in children.

Authors:  M L Everard
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

Review 5.  Chronic obstructive pulmonary disease and asthma. General and medical management with special attention to exacerbations.

Authors:  J P Kaajan
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

6.  Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.

Authors:  B M Zainudin; S E Tolfree; M Short; S G Spiro
Journal:  Thorax       Date:  1988-12       Impact factor: 9.139

7.  Proportional mouse model for aerosol infection by influenza.

Authors:  R S McDonald; A R Sambol; B K Heimbuch; T L Brown; S H Hinrichs; J D Wander
Journal:  J Appl Microbiol       Date:  2012-08-21       Impact factor: 3.772

8.  Containment of procedure-associated aerosols by an extractor tent: effect on nebulized drug particle dispersal.

Authors:  M Fennelly; J Keane; L Dolan; B J Plant; D J O'Connor; J R Sodeau; M B Prentice
Journal:  J Hosp Infect       Date:  2021-01-20       Impact factor: 3.926

9.  Controlled inhalation improves central and peripheral deposition in cystic fibrosis patients with moderate lung disease.

Authors:  Crystal Bourke; Sunalene Devadason; William Ditcham; Julie Depiazzi; Mark L Everard
Journal:  J Paediatr Child Health       Date:  2022-02-17       Impact factor: 1.929

10.  Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model.

Authors:  Sophie Perinel; Lara Leclerc; Nathalie Prévôt; Agathe Deville; Michèle Cottier; Marc Durand; Jean-Michel Vergnon; Jérémie Pourchez
Journal:  Respir Res       Date:  2016-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.